Pancreatic Cancer
Pancreatic cancer is a form of cancer that develops when cells in the pancreas, a glandular organ located behind the stomach, begin to multiply uncontrollably and form a mass. These cancerous cells can invade other parts of the body, and there are several types of pancreatic cancer.
Health Outcomes
- Accelerated Recovery of Chemotherapy-Induced Myelosuppression
- Activated Wnt/Beta-Catenin Signaling
- Activated p53/BAX-Mediated DNA Damage Response
- Additive Antitumorigenic Effect
- Attenuated Apoptosis
- Cancer Treatment Support
- Delayed Tumor Onset
- Downregulated Hippo Pathway Kinase Activity
- Enhanced Anticancer Capacity
- Enhanced Antitumor Immunity
- Enhanced CD8+ T Cell Infiltration
- Enhanced Carcinogenic Heterocyclic Amine Transformation
- Enhanced Caspase-3 Activity
- Enhanced Cell Viability
- Enhanced Cytolytic Response of CD8+ T Cells
- Enhanced Glycolysis Pathway Activation
- Enhanced Natural Killer Cell Activity
- Enhanced Natural Killer Cell Tumor Killing Activity
- Enhanced Pancreatic Health
- Enhanced Protein Kinase C Activity
- Enhanced Survival Without Side Effects
- Enhanced Tumor-Targeted Drug Delivery
- Improved Cell Viability
- Improved Chemotherapy Efficacy
- Improved Effectiveness in Cancer Treatment
- Improved Histopathological Indicators
- Improved NK-Cell Cytotoxicity
- Improved Natural Killer Cell Activation
- Improved Natural Killer Cell Activity
- Improved Natural Killer Cell Tumoricidal Activity
- Improved Objective Response Rate
- Improved Oncolytic Virotherapy Efficacy
- Improved Overall Survival
- Improved Pancreatic Tissue Repair
- Improved Pathological Response
- Improved Progression-free Survival
- Improved Resistance to Sodium Selenite
- Improved Response to PD-1 Immunotherapy
- Improved Survival
- Improved Survival Capacity
- Improved Survival Rate in Digestive Conditions
- Improved Survival Under Gastrointestinal Conditions
- Improved Survival at 24 Months
- Improved Survival in Digestive Environment
- Improved Therapeutic Potential
- Improved Treatment Response Rate
- Improved Tumor Response
- Inactivated Other Receptor Tyrosine Kinase Activity
- Increased Anti-Tumor Activity
- Increased Antiangiogenic Activity
- Increased Anticancer Activity
- Increased Cell Death
- Increased Cell Division
- Increased Cellular Adhesion
- Increased Cholecystokinin Level
- Increased Chromosomal Instability
- Increased Expression of Oxidation-Related Gene
- Increased Expression of Pro-apoptotic Proteins
- Increased Fecal Acidic Steroid Levels
- Increased Glycolysis Pathway Activity
- Increased Intratumoral Accumulation
- Increased Mitogenic Activity
- Increased NK Cell Activity
- Increased Peroxidase Activity
- Increased Polyamine Production
- Increased Pro-apoptotic Factor Levels
- Increased Protease Activity
- Increased Reduced Glutathione Level
- Increased Serum Amylase Activity
- Increased Serum Lipase Levels
- Increased Survival in Tumor-Bearing Mice
- Increased Telomere Length
- Increased Tissue Invasion
- Increased mTORC1 Activation
- Induced Glycolysis Pathway in Gastrointestinal Tract
- Inhibited Activation of Apoptotic Biomarkers
- Inhibited Digestive Enzyme Activity
- Inhibited EGF Receptor Signaling
- Inhibited Epithelial-Mesenchymal Transition
- Inhibited PI3K-Akt-mTOR Signaling
- Inhibited PI3K/AKT Pathway
- No Improvement in Objective Cancer Treatment Response
- Overall Treatment Success
- Reduced Alpha-Amylase Activity
- Reduced Amylase Level
- Reduced Apoptosis Due to Carcinogens
- Reduced Appetite
- Reduced Bax/Bcl-2 Ratio
- Reduced CEA Levels
- Reduced Cancer Progression
- Reduced Cancer-Related Inflammation
- Reduced Cancer-Specific Mortality
- Reduced Caspase-3 Activity
- Reduced Cell Apoptosis
- Reduced Cell Viability
- Reduced Chemotherapy Side Effects
- Reduced Chemotherapy-Induced Diarrhea
- Reduced Epithelial Cell Apoptosis
- Reduced Epithelial-Mesenchymal Transition
- Reduced Fas Level
- Reduced Fusobacterium Nucleatum Levels
- Reduced Gastrointestinal Toxicity
- Reduced Genotoxicity
- Reduced Glucagon Levels
- Reduced Insulin Level
- Reduced Pancreatic Bacterial Penetration
- Reduced Plasma Vitamin K Levels
- Reduced Postprandial Insulin Response
- Reduced Pulmonary Metastasis
- Reduced Risk of Cancer
- Reduced Serum Somatostatin Levels
- Reduced Survival Rate
- Reduced Tumor Formation
- Reduced Tumor Grade
- Reduced Tumor Growth
- Reduced Tumor Growth Rate
- Reduced Tumor Incidence
- Reduced Tumor Multiplicity
- Reduced Tumor Risk
- Reduced Tumor Stage
- Reduced Tumor Volume
- Restored Digestive Enzyme Activity
- Shifted Tumor-Associated Macrophages Toward Pro-Inflammatory M1 Polarization
- Suppressed Tumor Growth
- Suppressed Wnt/β-catenin Signaling
- Targeted Tumor Reduction
- Unchanged Survival Rate